Max Robotics — Global Service Robot Directory + US Certification

About

Nai-Kuan Chou is a pioneering cardiac surgeon whose work has significantly advanced the field of robotic-assisted heart surgery, with a particular focus on mitral valve repair and hypertrophic cardiomyopathy (HCM) treatment. Based at National Taiwan University Hospital, Chou has built a distinguished career championing minimally invasive robotic surgical techniques as transformative alternatives to conventional open-heart procedures. His most cited work, "Robotic Transmitral Approach for Hypertrophic Cardiomyopathy With Systolic Anterior Motion" (2018, 13 citations), demonstrated the viability of robotic myectomy for symptomatic HCM patients, a technically demanding procedure traditionally performed through open surgery. His landmark ten-year institutional outcomes study on robotic mitral valve repair and his comparative analysis of robotic versus conventional sternotomy in redo mitral surgery — each garnering 7 citations — have provided valuable evidence supporting robotic surgery's safety and efficacy, even in high-risk reoperative cases. Collectively, Chou's research highlights the clinical benefits of robotic platforms, including reduced surgical trauma, preserved thoracic integrity, and enhanced visualization, helping establish robust evidence for adopting these technologies in complex cardiac interventions across Asia and beyond.